Leerink Partnrs Issues Optimistic Forecast for PRVA Earnings

Privia Health Group, Inc. (NASDAQ:PRVA) – Investment analysts at Leerink Partnrs lifted their FY2025 earnings estimates for Privia Health Group in a report released on Tuesday, September 23rd. Leerink Partnrs analyst W. Mayo now expects that the company will post earnings per share of $0.23 for the year, up from their previous forecast of $0.21. The consensus estimate for Privia Health Group’s current full-year earnings is $0.14 per share. Leerink Partnrs also issued estimates for Privia Health Group’s Q4 2025 earnings at $0.09 EPS, Q4 2026 earnings at $0.12 EPS, FY2026 earnings at $0.42 EPS, FY2027 earnings at $0.57 EPS, FY2028 earnings at $0.76 EPS and FY2029 earnings at $0.99 EPS.

Several other research firms have also weighed in on PRVA. JMP Securities upped their price target on Privia Health Group from $29.00 to $30.00 and gave the company a “market outperform” rating in a research report on Friday, August 29th. Piper Sandler lowered their target price on Privia Health Group from $36.00 to $35.00 and set an “overweight” rating on the stock in a research note on Monday, August 11th. Citigroup reissued an “outperform” rating on shares of Privia Health Group in a research report on Friday, August 29th. Stephens reaffirmed an “overweight” rating and set a $32.00 price objective on shares of Privia Health Group in a research report on Wednesday. Finally, Evercore ISI dropped their price objective on shares of Privia Health Group from $30.00 to $28.00 and set an “outperform” rating on the stock in a research note on Wednesday, July 9th. One research analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $28.58.

Privia Health Group Stock Up 0.1%

PRVA opened at $23.36 on Thursday. The firm has a market capitalization of $2.87 billion, a P/E ratio of 212.38, a PEG ratio of 3.29 and a beta of 0.82. The stock has a fifty day moving average of $21.44 and a 200-day moving average of $22.40. Privia Health Group has a 12-month low of $16.47 and a 12-month high of $26.09.

Privia Health Group (NASDAQ:PRVA) last issued its quarterly earnings results on Thursday, August 7th. The company reported $0.02 EPS for the quarter, missing the consensus estimate of $0.05 by ($0.03). Privia Health Group had a net margin of 0.78% and a return on equity of 2.13%. The firm had revenue of $521.15 million during the quarter, compared to analysts’ expectations of $466.97 million. During the same quarter last year, the company posted $0.19 EPS. The firm’s revenue was up 23.4% compared to the same quarter last year. Privia Health Group has set its FY 2025 guidance at EPS.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of PRVA. Thrivent Financial for Lutherans lifted its stake in shares of Privia Health Group by 1.7% in the 2nd quarter. Thrivent Financial for Lutherans now owns 77,099 shares of the company’s stock valued at $1,773,000 after purchasing an additional 1,296 shares during the last quarter. State of Wyoming increased its position in Privia Health Group by 162.6% during the second quarter. State of Wyoming now owns 32,320 shares of the company’s stock worth $743,000 after buying an additional 20,010 shares during the last quarter. Caxton Associates LLP bought a new position in Privia Health Group during the second quarter valued at about $329,000. Public Sector Pension Investment Board lifted its position in shares of Privia Health Group by 9.2% in the second quarter. Public Sector Pension Investment Board now owns 357,503 shares of the company’s stock worth $8,223,000 after buying an additional 30,256 shares during the last quarter. Finally, Tower Research Capital LLC TRC boosted its stake in shares of Privia Health Group by 601.7% during the 2nd quarter. Tower Research Capital LLC TRC now owns 10,547 shares of the company’s stock worth $243,000 after acquiring an additional 9,044 shares in the last quarter. Institutional investors and hedge funds own 94.48% of the company’s stock.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.